Missouri Delta Medical Center Acquires ION Robot for Earlier Lung Cancer Detection
Missouri Delta Medical Center is pleased to announce the upcoming acquisition of the Ion endoluminal system.
Missouri Delta Medical Center is pleased to announce the upcoming acquisition of the Ion endoluminal system.
While the clinic remains open during construction, plans are for the pharmacy to be fully operational by early summer.
Under the program, Missouri Delta patients will be screened to determine food insecurity issues. Those who are identified will receive a box of healthy foods, including items like canned vegetables and peanut butter, to take home with them upon discharge.
The vestibular system includes the parts of the inner ear and brain that process the sensory information involved with controlling balance and eye movements.
To celebrate 100 years of helping hospitals, Missouri Hospital Association (MHA) solicited hundreds of stories of individuals representing the hospitals throughout Missouri. Our very own Eric Slaughter, RN, BSN, was chosen for their Top 100! #MoHospitals100
As a not-for-profit hospital, we are required to conduct a Community Health Needs Assessment (CHNA) every three years for the geographic area from which a significant number of patients using MDMC services reside.
When a baby dies before it’s born or shortly after, parents often do not have much time with their child or the opportunity to say goodbye.
A new tool that provides the earliest detection and staging of lung cancer will soon be available to Sikeston-area residents.
Missouri Delta Medical Center held a groundbreaking, December 8, 2021, on a state of the art 23,189 square foot, single-story building located on three acres of land adjacent to the existing Bruce Medical Building on Plaza Drive.
“Over the course of COVID-19 and its disastrous implications on physical health and its associated social outcomes, we have been protected by the conviction and tireless efforts of our frontline workers. We commend and salute these brave actions and seek to investigate and formulate the clinical transition of COVID-19.”